Thyrosequence testing service
Active Awarded Last action
- Contract number
- 36C24226N0332
- Awardee
-
Cytopath Biopsy Lab Inc. UEI KC5VWAGMNLT6
- Awarding agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $60,000
Award facts
- Contract value 100% obligated
- $60,000.00 Current and potential, with all options
- Completion date 34% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10010, USA
Award details come from SAM.gov/FPDS.
About this award
Cytopath Biopsy Lab Inc., operating as Cblpath, was awarded a $60,000 delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) on February 13, 2026, for ThyroSequence testing services. This firm fixed-price delivery order, with an ultimate completion date of February 12, 2028, will be performed in New York, NY and does not utilize a small business set-aside designation. The award leverages an existing Indefinite Delivery Contract (IDC) mechanism with VISN 2 that was established in February 2023 with a $1.8 million ceiling value, of which this delivery order represents a task call-down.
Cblpath has established itself as a specialized provider of molecular diagnostic laboratory services to the federal healthcare system, with particular expertise in ThyroSeq—a proprietary genomic sequencing technology that analyzes thyroid nodules to assess cancer risk. The company maintains a substantial federal contracting portfolio across multiple Veterans Integrated Service Networks and other healthcare agencies, with over 50 contract awards since 2021 ranging from $2,000 to $2.31 million. All of Cblpath's federal contract awards employ firm fixed-price structures without set-aside designations, reflecting the company's competitive positioning as a prime contractor capable of serving federal healthcare agencies independently.
Quick answers
Who was awarded contract 36C24226N0332?
36C24226N0332 was awarded to Cytopath Biopsy Lab Inc. by Veterans Integrated Service Network 2 (Veterans Health Administration) on February 13, 2026.
How much is contract 36C24226N0332 worth?
The government has obligated $60,000 on 36C24226N0332.
Is contract 36C24226N0332 an order under another contract?
Yes. 36C24226N0332 is a delivery order under 36C24223D0044, an indefinite delivery contract.
Was contract 36C24226N0332 competed?
The extent of competition for 36C24226N0332 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award